Brandon Matthew Hayes-Lattin MD
Hematologic Oncology
Professor of Medicine, Medical Director of Hematology and Medical Oncology
Join to View Full Profile
3181 SW Sam Jackson Park Rd# L586Portland, OR 97239
Phone+1 503-494-8534
Fax+1 503-494-3257
Dr. Hayes-Lattin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2001 - 2004- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of Washington School of MedicineClass of 1997, MD
StanfordBS, 1988 - 1992
Certifications & Licensure
WA State Medical License 2005 - 2026
OR State Medical License 1998 - 2025
American Board of Internal Medicine Hematology
Clinical Trials
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine
Transplantation and Cellular Therapy. 2025-11-08 - 2 citationsPrimary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplan...Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Joseph Pidala
Journal of Clinical Oncology. 2025-11-01 - 1 citationsGenetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, Emmanuelle Tavernier-Tardy, Fangyan Dai
Blood Cancer Discovery. 2025-09-03
Press Mentions
The Knight Cancer Challenge’s Enduring Legacy: Celebrating a Decade of Cancer Research, Care, PreventionJune 24th, 2025
Raising Awareness of the Financial Impact of Cancer on Young Adult SurvivorsJuly 10th, 2018
How to Help Young Patients Preserve Their FertilityAugust 10th, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
